![Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success](/i/c/8af79b5e-72ef-4fc9-41b3-a8f93180bb24.webp)
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:45
![Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy](/i/c/30b3df02-1e66-d166-e883-03a05eed03e8.webp)
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29